Medicines, Devices & Lab Equipment

The thesis

Own healthcare product manufacturers rather than insurers or care-delivery platforms, combining prescription medicines with medical devices and laboratory equipment. The technology drawdown makes a business-driven diversification sleeve timely, while Lilly's reimbursement debate highlights the importance of separating underlying demand from realized pricing. Drug pricing, clinical execution and hospital purchasing remain risks; this is not a claim that healthcare is immune to a selloff.